FDA Updates on Compounded GLP-1 Medications Key Changes & Impact The U.S

( It is noteworthy that the gut microbiota functions as a central mediator in the bidirectional communication between the GI system and the brain, a network commonly known as the microbiotagutbrain axis ( The term experienced a semantic evolution in 1965, when Lilly and Stillwell redefined it to describe metabolites secreted by one microorganism that stimulate the growth of another ( A further key refinement in 1998 emphasized that such benefits occur only when probiotics are administered at sufficient doses ( The panel concluded that probiotic efficacy is both strain-specific and dose-dependent, indicating that health benefits demonstrated by one strain cannot necessarily be generalized to others, even within the same species ( Lactobacillus , Bifidobacterium , Bacillus , and Pediococcus , as well as certain yeast species ( Robust clinical evidence supports the use of specific probiotic strains in managing GI disorders such as irritable bowel syndrome (IBS), Helicobacter pylori infection, inflammatory bowel disease (IBD), and infectious diarrhea ( Simultaneously, several meta-analyses and guideline panels highlight that many claimed indications are supported only by low- to moderate-quality evidence, with significant heterogeneity between trials and frequent failure of some strains or formulations to demonstrate superiority over placebo in rigorous, well-controlled studies ( This review examines the mechanisms of action of probiotics and summarizes current evidence regarding their effects on human health

Synergistic Effects of Curcumin and Piperine as Potent Acetylcholine and Amyloidogenic Inhibitors with Significant Neuroprotective Activity in Sh-Sy5y Cells via Computational Molecular Modeling and in Vitro Assay. Frontiers in Aging Neuroscience 10 (JUL): 206
handle gently to avoid degradation
[Google Scholar] 76.Ta N.N., Schuyler C.A., Li Y., Lopes-Virella M.F., Huang Y